Quantification Of Left Ventricular Mass Research Articles

Measurement of Left Ventricular Mass by Real-Time Three-Dimensional Echocardiography: Validation Against Magnetic Resonance and Comparison with Two-Dimensional and M-Mode Measurements

The recent development of 3-dimensional (3D) surface detection algorithm of the endocardial and epicardial surfaces from real-time 3D echocardiographic (RT3DE) datasets allows direct semiautomated quantification of left ventricular mass (LVM). Our aims were to (1) evaluate the accuracy of RT3DE measurements of LVM using this algorithm against cardiac magnetic resonance (CMR) reference and (2) compare RT3DE LVM with conventional M-mode, 2-dimensional (2D), and RT3DE-guided biplane measurements. A total of 205 patients were studied in 2 protocols: (1) RT3DE and CMR imaging was performed on the same day in 55 subjects; (2) in an additional 150 subjects, RT3DE, 2D, and M-mode images were acquired. In both protocols, RT3DE endocardial and epicardial surfaces were semiautomatically identified at end diastole (QLab, Philips Medical Systems, Andover, MA) to calculate LVM. CMR, 2D, and M-mode-derived LVM were obtained using standard techniques. A significant correlation (r = 0.95) was noted between RT3DE and CMR-derived LVM with a small bias of -2 g. M-mode-derived LVM measurements (175 +/- 64 g) were significantly larger than RT3DE LVM (123 +/- 39 g, bias: 52 g) with moderate correlation (r = 0.76). No significant differences in LVM were noted between 2D (125 +/- 42 g) and RT3DE values (bias: 1.2 g) with good correlation (r = 0.91, P < .001). However, the best correlation was noted between RT3DE and RT3DE-guided biplane LVM values (r = 0.95, P < .001, bias: -4.6 g). Intraobserver, interobserver variability, and test-retest variability of the RT3DE measurements were 9%, 12%, and 6%, respectively. RT3DE imaging using the 3D surface detection algorithm allows accurate and reproducible measurements of LVM. RT3DE-guided biplane technique can be used as an accurate time-saving alternative in clinical practice.

Effects of papillary muscles and trabeculae on left ventricular quantification: increased impact of methodological variability in patients with left ventricular hypertrophy

Accurate quantification of left ventricular mass and ejection fraction is important for patients with left ventricular hypertrophy. Although cardiac magnetic resonance imaging has been proposed as a standard for these indices, prior studies have variably included papillary muscles and trabeculae in myocardial volume. This study investigated the contribution of papillary muscles and trabeculae to left ventricular quantification in relation to the presence and pattern of hypertrophy. Cardiac magnetic resonance quantification was performed on patients with concentric or eccentric hypertrophy and normal controls (20 per group) using two established methods that included papillary muscles and trabeculae in myocardium (method 1) or intracavitary (method 2) volumes. Among all patients, papillary muscles and trabeculae accounted for 10.5% of ventricular mass, with greater contribution with left ventricular hypertrophy than normals (12.6 vs. 6.2%, P < 0.001). Papillary muscles and trabeculae mass correlated with ventricular wall mass (r = 0.53) and end-diastolic volume (r = 0.52; P < 0.001). Papillary muscles and trabeculae inclusion in myocardium (method 1) yielded smaller differences with a standard of mass quantification from linear ventricular measurements than did method 2 (P < 0.001). Method 1 in comparison with method 2 yielded differences in left ventricular mass, ejection fraction and volume in all groups, especially in patients with hypertrophy: the difference in ventricular mass index was three-fold to six-fold greater in hypertrophy than normal groups (P < 0.001). Difference in ejection fraction, greatest in concentric hypertrophy (P < 0.001), was independently related to papillary muscles and trabeculae mass, ventricular wall mass, and smaller ventricular volume (R = 0.56, P < 0.001). Established cardiac magnetic resonance methods yield differences in left ventricular quantification due to variable exclusion of papillary muscles and trabeculae from myocardium. The relative impact of papillary muscles and trabeculae exclusion on calculated mass and ejection fraction is increased among patients with hypertrophy-associated left ventricular remodeling.

Determination of left ventricular mass by three-dimensional echocardiography: in vitro validation of a novel quantification method using multiple equi-angular rotational planes for rapid measurements.

Measuring left ventricular mass by m-mode echocardiography or two-dimensional echocardiography is limited by the fact that calculations are based on assumptions, which describe left ventricular shape by simple geometric figures. The ability of three-dimensional echocardiography (3-DE) to accurately assess left ventricular mass has been shown previously, but 3-DE approaches to quantitative analysis of ventricular mass required multiple tomographic sectioning, manual tracing in various cut planes and were time consuming and laborious. We investigated the accuracy of a novel, rapid method of 3-DE mass quantification using multiple rotational planes in left ventricles in vitro. Three-dimensional data sets of 10 fixed pig hearts were obtained using a TomTec 3-DE system. For 3-DE mass calculations, a rotational axis in the center of the ventricle (apical-basal orientation) was defined and 3, 6 and 12 equi-angular rotational planes were created. The endocardial and epicardial contour of the left ventricle was traced in each cut plane and the volume of the corresponding myocardial wedge was automatically calculated. Mass was calculated by multiplying the resulting myocardial volume by the specific weight of myocardial tissue. The measurements were performed by two investigators blinded to the anatomic true mass and were analyzed for interobserver and intraobserver variability. The anatomic left ventricular mass was measured 73-219 (168 +/- 50) g. 3-DE mass ranged from 88-247 (207 +/- 51) g (three planes), 84-250 (205 +/- 52) g (six planes) and 86-241 (202 +/- 50) g (12 planes) respectively. The correlation between 3-DE mass and anatomic LV mass measurements (r = 0.92) and between two observers (r = 0.97-0.98) was good. True mass was slightly overestimated by 3-DE measurement (SEE = 22-23 g). The intraobserver and interobserver variabilities were < or = 4 and < or = 7% respectively for all measurements. This new 3-DE method of left ventricular mass quantification with rotational approach provides accurate and reproducible measurements. In normal shaped left ventricles even three planes were sufficient to provide accurate mass measurements in vitro.

Ventricular hypertrophy in sleep apnoea.

Ventricular hypertrophy is associated with an increased risk of cardiovascular death and cardiac events. In response to a haemodynamic load, ventricular hypertrophy may either be eccentric (dilation in response to volume overload) or concentric (increase in wall thickness in response to pressure overload). Ventricular hypertrophy increases with age, weight, blood pressure, and the presence of cardiovascular disease. It is greater in men than in women when adjusting for other variables. Echocardiography is the best method for accurate quantification of left ventricular mass and for detecting right ventricular hypertrophy. In obstructive sleep apnoea there are reports of both eccentric and concentric hypertrophy of the left ventricle. However, many of these reports have failed to control for patient weight or age. More recent reports indicate that much of the hypertrophy of the left ventricle reported in obstructive sleep apnoea can be related to patients' age, blood pressure, or size. However, right ventricular hypertrophy appears to be distinctly associated with the presence and severity of obstructive sleep apnoea. Right ventricular hypertrophy secondary to obstructive sleep apnoea may be the substrate for the eventual development of cor pulmonale and right heart failure. Its pathophysiological significance and potential use as a marker of severe OSA requires further investigation. Further investigation into left ventricular hypertrophy and sleep apnoea must control for the potentially confounding variables listed above and will require population-based and/or carefully matched case control studies.

Cross-sectional echocardiography. I. Analysis of mathematic models for quantifying mass of the left ventricle in dogs.

Cross-sectional echocardiography was used to quantify left ventricular mass noninvasively in 21 dogs. Short- and long-axis cross-sectional images of the left ventricle were reproducibly traced at endocardial and epicardial borders during stop-motion video-tape replay. We used area, length and diameter measurements to calculate left ventricular mass by seven mathematic models, including the standard formulas used with M-mode echocardiography and cineangiography. Calculated mass was compared with excised weight of the left ventricle by regression and percent error analyses. Formulas using short-axis areas and long-axis length resulted in higher correlation coefficients (0.94--0.95) and lower mean errors (6--7%) than for standard formulas. Since short-axis areas account for regional left ventricular irregularities, noninvasive quantification of left ventricular mass by cross-sectional echocardiography in dogs is most accurate with formulas using short-axis areas.